Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
about
Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)New obesity classification criteria as a tool for bariatric surgery indicationSkeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise trainingMechanisms of Muscle Denervation in Aging: Insights from a Mouse Model of Amyotrophic Lateral SclerosisLive imaging of muscle histolysis in Drosophila metamorphosisA model of muscle atrophy based on live microscopy of muscle remodelling in Drosophila metamorphosis.Human Skeletal Muscle Disuse Atrophy: Effects on Muscle Protein Synthesis, Breakdown, and Insulin Resistance-A Qualitative ReviewA comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patientsSelf-reported sleep duration and time in bed as predictors of physical function decline: results from the InCHIANTI studyA novel glycerophosphodiester phosphodiesterase, GDE5, controls skeletal muscle development via a non-enzymatic mechanismMyostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wastingValidation of ultrasonographic muscle thickness measurements as compared to the gold standard of computed tomography in dogs.Assessing skeletal muscle mass: historical overview and state of the artIngestion of low-dose ibuprofen following resistance exercise in postmenopausal womenGeneration of eX vivo-vascularized Muscle Engineered Tissue (X-MET).Cited3 activates Mef2c to control muscle cell differentiation and survival.Subtypes of physical frailty: Latent class analysis and associations with clinical characteristics and outcomes.Sarcopenia and the analysis of body composition.Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysisImpact of underweight after treatment on prognosis of advanced-stage ovarian cancer.Bedrest and sarcopeniaDexamethasone-induced autophagy mediates muscle atrophy through mitochondrial clearance.Managing sarcopenia and its related-fractures to improve quality of life in geriatric populations.The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilizationNFATc1 controls skeletal muscle fiber type and is a negative regulator of MyoD activity.Delayed recovery of skeletal muscle mass following hindlimb immobilization in mTOR heterozygous mice.Chronic α-hydroxyisocaproic acid treatment improves muscle recovery after immobilization-induced atrophy.Mammalian models of extended healthy lifespan.Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factorsSREBP-1 transcription factors regulate skeletal muscle cell size by controlling protein synthesis through myogenic regulatory factors.Decrease in urinary creatinine excretion in early stage chronic kidney disease.Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals.Important aspects of nutrition in children with cancer.Are older adults with chronic musculoskeletal pain less active than older adults without pain? A systematic review and meta-analysis.Aging reduces asymmetries in interlimb transfer of visuomotor adaptationA dietary supplementation with leucine and antioxidants is capable to accelerate muscle mass recovery after immobilization in adult ratsCancer cachexia update in head and neck cancer: Pathophysiology and treatment.
P2860
Q26747940-5B4A3FF1-5C28-4CA4-ACB7-47A47A032484Q26774656-0594B37E-3024-428D-BEF8-63D97563BD0EQ26781640-970B2ABF-E11A-4DBF-929E-0FCDB9D28901Q26783337-72DA97B3-CBBD-42C9-A678-35A799E40E25Q27318506-C2180635-D339-4FE0-913B-BB8261A35B62Q27334997-D05DE2BC-6D47-44F1-8D26-1B6BE4AA5F29Q28077935-427A6A7B-066E-42A6-997B-E24C63C02DB9Q28364947-7C90D373-FA68-4280-9064-6C8651597167Q28392898-1689C33A-F397-4C59-9D2A-067A86B34505Q28509552-F24DD411-1B1A-4103-BBF6-FA3A61A03D29Q28588473-8E8ED916-FE3F-4566-9F9B-1B878B711DE2Q30364726-5EE3F937-83F3-441E-BF43-9C4DA3C3CD01Q30441307-AD6C2F67-5B82-4557-9230-749A957F0EDDQ30457751-64C3DDA0-A22E-47AC-BF77-02FDB27324D2Q30537442-842E83FF-56E4-4B8A-A13A-98BE71BF722DQ30539802-1B91EFB3-E4D6-436E-BAD5-FE188AA01A38Q33551664-CE704B2B-2E1E-4E66-A3EE-B0A2B622ED88Q33578662-E6A86B2D-69A0-48CE-8D11-F3DD0622F2F2Q33628125-69F744A0-E664-4F5B-82C6-EAE4AFB52FB9Q33718752-50BFEEBE-6549-45C8-AF66-30959EB1C11AQ33890809-BCBA3228-EFAD-412C-9EF3-77FC16625F75Q33908313-1D1BDE0C-394E-4BB6-9175-563482CAD3E1Q33952822-FCDF53B9-F973-4A8D-84A1-3AFEE672A804Q33962042-F760E39F-180C-48C2-BC85-9C68D9D74F28Q34029187-51B1D1D3-C2C1-4D54-9B47-A3A5DCD01FE6Q34203697-4124694C-25D7-44E8-83D2-763253D271B1Q34266794-DC57D4CB-CEF4-4541-B5B1-D8BDCBB730DAQ34321178-63531F9B-4974-451B-BF3A-D2CE49036270Q34350231-7485435F-304E-4D08-816D-B1B6DF444952Q34402689-7998D6DF-A82D-469F-965D-7822182ED813Q34413219-B481272D-0DB4-4938-B758-1761DB231FD4Q34506085-6B4FD4DF-276C-4345-8ED6-487B56365356Q34523616-720DD337-2B78-4D78-9577-4AE35888B48FQ34556525-F2969A63-FB25-4CEF-A850-AD3C93343860Q34584634-E612D8BE-87C6-4797-BAA5-D484560D79BBQ34729831-FE7B3E04-4B80-49D5-8DB7-207A1C312AB9Q34761726-E592385A-8E43-412F-96DB-652D4D09C522Q35050396-3ECD1E1A-8489-4708-A748-3EE9001C6F23Q35060561-56222EBE-243F-4B7B-AC7D-37C4A91F81F0Q35122201-06B63B2A-B854-4B13-80DF-228936BA2F19
P2860
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
@ast
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
@en
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
@nl
type
label
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
@ast
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
@en
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
@nl
prefLabel
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
@ast
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
@en
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
@nl
P356
P1476
Skeletal muscle loss: cachexia, sarcopenia, and inactivity.
@en
P2093
William J Evans
P304
1123S-1127S
P356
10.3945/AJCN.2010.28608A
P407
P577
2010-02-17T00:00:00Z